GSK-204836

Study Sponsor: GSK

Study Title

A 29-day, randomized, double-blinded, placebo-controlled, parallel-group, multi-center study to evaluate the efficacy, safety and pharmacokinetics of three-times weekly dosing of GSK1278863 in hemodialysis-dependent subjects with anemia associated with chronic kidney disease who are switched from a stable dose of an erythropoiesis-stimulating agent

Medicine or Vaccine (generic name)

daprodustat

Sponsor Identification Number

204836

Trial Registry Identification Number(#'s)

NCT02689206 2015-004790-32

Medical Condition

Anaemia

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=204836

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02689206

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2015-004790-32

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

November 2019